The Impact of Climatic Factors on Respiratory Pharmaceutical Demand: A Comparison of Forecasting Models for Greece

Viviana Schisa, Matteo Farnè · 2025

Read The Impact of Climatic Factors on Respiratory Pharmaceutical Demand: A Comparison of Forecasting Models for Greece by Viviana Schisa, Matteo Farnè (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2505-10642.txt.

Introduction

Viviana Schisa and Matteo Farnè study how weather shapes weekly demand for respiratory medicines in Greece. Climate change is known to affect health, but its pull on drug demand is little studied. Their 2025 study uses seven and a half years of weekly data and first tests which climate factors lead demand.

Four forecasting models were then compared. A random forest variant gave the best scores on relative error and ranked the driving factors clearly. A neural network model won on most other measures, catching curved patterns well. A vector model fed with inputs from a trend tool balanced clarity and accuracy. The authors say climate aware forecasts can help health systems plan supply under a changing climate.

Catalog record

CREATORViviana Schisa, Matteo Farnè
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE109 KB
VERSION1.0
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2505-10642

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The Impact of Climatic Factors on Respiratory Pharmaceutical Demand: A Comparison of Forecasting Models for Greece Viviana Schisa, Matteo Farnè Abstract Climate change is increasingly recognized as a driver of health-related outcomes, yet its impact on pharmaceutical demand remains largely understudied. As environmental conditions evolve and extreme weather events intensify, anticipating their influence on medical needs is essential for designing resilient healthcare systems. This study examines the relationship between climate variability and the weekly demand for respiratory prescription pharmaceuticals in Greece, based on a dataset spanning seven and a half years (390 weeks). Granger causality spectra are employed to explore potential causal relationships. Following variable selection, four forecasting models are implemented: Prophet, a Vector Autoregressive model with exogenous variables (VARX), Random Forest with Moving Block Bootstrap (MBB-RF), and Long Short-Term Memory (LSTM) networks. The MBB-RF model achieves the best performance in relative error metrics while providing robust insights through variable importance rankings. The LSTM model outperforms most metrics, highlighting its ability to capture nonlinear dependencies. The VARX model, which includes Prophet-based exogenous inputs, balances interpretability and accuracy, although it is slightly less competitive in overall predictive performance. These findings underscore the added value of climate-sensitive variables in modeling pharmaceutical demand and provide a data-driven foundation for adaptive strategies in healthcare planning under changing environmental conditions. 1 Introduction Climate change represents one of the foremost challenges of recent decades, with profound impacts on environmental systems, public health, and the global economy. This phenomenon is projected to exacerbate global inequality and public health risks, pushing more than 100 million into poverty and limiting access to vital resources such as food, clean water, and healthcare ( World Bank, 2016 ) . These deprivations are expected to raise both mortality and morbidity rates. According to WHO projections, climate change could be responsible for 250,000 additional deaths annually between 2030 and 2050, primarily through direct health threats ( World Health Organization et al., 2014 ) . Furthermore, climate change could increase global mortality risk by approximately 3.2% of global GDP by 2100 under a high emissions scenario according to projections by Carleton et al., 2022 . 1 1 1 Damages are expressed in terms of the Value of a Statistical Life (VSL), an economic measure of the value placed on reducing the risk of death. The VSL is derived from the willingness to pay for marginal reductions in mortality risk. It is used in cost-benefit analyses to assess the economic impacts of policies that affect health and safety. Beyond macroeconomic estimates, climate change is most notably expected to reshape individual health trajectories and treatment needs, altering disease incidence and drug demand, particularly in the context of rising chronic conditions and increased exposure to environmental stressors. Due to global warming, the Northern Hemisphere is expected to face not only hotter summers but also more extreme winter conditions. Although average winter temperatures may rise, climate projections indicate an increased likelihood of severe winter storms. These events often bring strong winds that amplify cold exposure, particularly among vulnerable populations, thereby increasing the risk of cold-related conditions such as hypothermia and frostbite. In addition, prolonged cold stress can impair immune defenses, making individuals more susceptible to respiratory infections ( Redshaw et al., 2013 ) . Rising temperatures, related increased air pollution and extended pollen seasons intensify respiratory and cardiovascular conditions ( Tran et al., 2023 ; D’Amato et al., 2014 ; Khraishah et al., 2022 ) . In parallel, water and soil quality degradation contribute to a rise in diarrheal diseases, especially in vulnerable populations. Furthermore, the spread of vector-borne diseases is extending into non-subtropical regions ( Rocklöv and Dubrow, 2020 ) , and rising anxiety, depression, and stress (related to extreme weather events, displacement, and environmental degradation) are increasingly associated with climate-related stressors and environmental disruptions ( Cianconi et al., 2020 ) . These diverse and compounding health stressors are expected to translate into increased pharmaceutical needs across populations. The multifaceted impacts of climate on both physical and mental health are expected to increase the consumption of medications for both targeted treatments (e.g., antiprotozoals, psychotropics) and general symptom management (e.g., analgesics) ( Redshaw et al., 2013 ) . Yet, the relationship between environmental stressors and pharmaceutical demand remains underexplored, even though pharmaceutical consumption could serve as a valuable proxy for climate-related health impacts. Climate change generally refers to long-term transformations in climate systems, but its health impacts can materialize through more immediate and localized events. This study focuses on short- to medium-term fluctuations in environmental conditions, which can be considered a tangible expression of climate change. In this sense, increased medication use may reflect heightened exposure to climate-related stressors, providing a quantifiable signal of population-level health impacts. Understanding these dynamics is crucial to anticipate healthcare needs and support pharmaceutical system resilience. Forecasting models can inform preparedness strategies, optimize resource allocation, and improve supply chain performance, particularly during climate-induced demand surges ( Toković, 2023 ) . Integrated forecasting models incorporating climate, epidemiological, and pharmaceutical data are essential to support policy responses and ensure equitable access to care. These complex interactions highlight the need for integrated surveillance systems, adaptation strategies, and mitigation efforts that can deliver both environmental and immediate health benefits ( Haines et al., 2006 ) . Accurate forecasting enables a proactive strategy to identify vulnerabilities and enhance the robustness of pharmaceutical distribution, e.g., through stockpiling or diversification of high-demand pharmaceuticals. In this context, the present study adopts a quantitative, data-driven approach to forecast respiratory medication demand under climate variability, with the aim of informing both public health policy and pharmaceutical supply chain design. Supply chain resilience can be enhanced by anticipating consumption trends in response to climate change and optimizing resource allocation and asset management, particularly during crises such as the COVID-19 pandemic. Nonetheless, assessing the impact of climate change on medical needs remains complex, as healthcare systems respond through a mix of short-term interventions and long-term policy adaptations—mechanisms that are often multifactorial, delayed, and mediated by socioeconomic conditions, infrastructure constraints, and limited access to granular health data ( Rocque et al., 2021 ) . Against this backdrop, this study seeks to quantify the impact of climate change on pharmaceutical demand, with a specific focus on respiratory treatments. Among the various health domains, respiratory diseases are especially climate-sensitive. According to D’amato et al., 2016 , global warming accentuates temperature variability, leading to higher concentrations of pollutants and extended pollen seasons, which increase allergen exposure and result in more frequent and severe asthma symptoms. Similarly, a survey conducted among physicians from the National Medical Association revealed that patients with COPD and asthma have experienced increased symptoms due to weather changes ( Sarfaty et al., 2014 ) . Consequently, the demand for asthma-related medications (e.g., inhalers and corticosteroids) and COPD treatments (e.g., bronchodilators and anti-inflammatory agents) is expected to increase during heightened environmental stress. Furthermore, projections from the system dynamics model proposed by Abir et al., 2025 suggest that the demand for the asthma pharmaceutical albuterol will likely increase across most age groups due to a heightened prevalence of asthma driven by climatic conditions. Moreover, Eguiluz-Gracia et al., 2020 discuss the contribution of climate change in exacerbating respiratory diseases, particularly among children, by highlighting how rising temperatures and altered

Read the complete text